Emmaus Life Sciences Inc (EMMAW) Inventory Turnover Ratio, from fourth quarter 2025 to fourth quarter 2024, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Emmaus Life Sciences Inc   (EMMAW)
 

Emmaus Life Sciences Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the fourth quarter 2025, Emmaus Life Sciences Inc 's inventory turnover ratio sequentially decreased to 0.48 in the fourth quarter 2025, unsurprisingly, as the Emmaus Life Sciences Inc markets continue to deteriorate, and EMMAW's faces growing challenges to bring down its inventories. Emmaus Life Sciences Inc 's average inventory processing period in the Dec 31 2025 quarter, has increased to 760 days, from 619 days, in the Jun 30 2025 quarter.

Within Healthcare sector 365 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the IV Quarter 2025, to 1703, from total ranking in the second quarter 2025 at 1779.

EMMAW Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Emmaus Life Sciences Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

EMMAW Inventory Turnover Ratio (Dec 31 2025)
IV. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter
Y / Y Inventory Growth -3.42 % -19.35 % -5.89 % -4.44 % -2.42 %
Y / Y Cost of Sales Growth -40.36 % -37.76 % -12.45 % -43.46 % 84.11 %
Inventory Turnover Ratio (TTM) 0.48 0.59 0.61 0.63 0.67
EMMAW's Total Ranking # 1703 # 1779 # 1402 # 1911 #
Average inventory processing period 755 624 595 584 546
Seq. Inventory Growth 18.43 % -8.63 % -12.11 % 1.55 % -1.11 %
Seq. Cost of Sales Growth 56.67 % -33.33 % 108.33 % -72.59 % 63.49 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 113
Healthcare Sector # 366
Overall Market # 1703

Inventory Turnover Ratio Statistics
High Average Low
1.15 0.61 0.17
(Sep 30 2022)   (Jun 30 2020)



EMMAW Company Profile >> Back to EMMAW Efficiency Comparisons >> Compare EMMAW Inventory Turnover Ratio to its Competitors

Financial Statements
Emmaus Life Sciences Inc 's Inventories $ 2 Millions Visit EMMAW's Balance sheet
Emmaus Life Sciences Inc 's Cost of Revenues TTM $ 1 Millions Visit EMMAW's Income Statement
What are EMMAW's Sales? Visit EMMAW's Sales by Segment

Other Inventory Turnover Ratios
Emmaus Life Sciences Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
EMMAW's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for EMMAW's Competitors
Inventory Turnover Ratio for EMMAW's Suppliers
Inventory Turnover Ratio for EMMAW's Customers

You may also want to know
EMMAW's Sales Growth Rates EMMAW's Pe Price to earnings ratio EMMAW's Receivables Turnover Ratio EMMAW's Stock Quote
EMMAW's Net Income Growth Rates EMMAW's Ps Price to Sales ratio EMMAW's Sales per Employee EMMAW's Asset Turnover Ratio
EMMAW's Net Margin EMMAW's Pb Price to Book ratio EMMAW's Financial Strength Ratios EMMAW's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Dec 31 2025 Inventories at quarter ending Dec 31 2025
Elanco Animal Health Incorporated  1.27 $ 2,122.000  Millions$ 1,677  Millions
Beone Medicines Ltd   1.25 $ 668.000  Millions$ 534  Millions
Protalix Biotherapeutics inc   1.23 $ 26.993  Millions$ 22  Millions
Si bone inc   1.22 $ 41.000  Millions$ 34  Millions
Delcath Systems Inc   1.22 $ 11.797  Millions$ 10  Millions
Sensus Healthcare Inc   1.20 $ 15.000  Millions$ 12  Millions
Biolife Solutions Inc   1.20 $ 34.000  Millions$ 28  Millions
Blue Water Vaccines Inc  1.20 $ 0.182  Millions$ 0  Millions
Edwards Lifesciences Corporation  1.18 $ 1,334.000  Millions$ 1,131  Millions
Assertio Holdings inc   1.17 $ 35.383  Millions$ 30  Millions
Cormedix Inc   1.16 $ 21.965  Millions$ 19  Millions
Bridgebio Pharma Inc   1.14 $ 20.962  Millions$ 18  Millions
Rxsight Inc   1.14 $ 31.021  Millions$ 27  Millions
60 Degrees Pharmaceuticals Inc   1.13 $ 0.782  Millions$ 1  Millions
Adma Biologics Inc   1.12 $ 215.347  Millions$ 192  Millions
IMPACT BIOMEDICAL INC.  1.11 $ 0.424  Millions$ 0  Millions
Cv Sciences Inc   1.11 $ 4.636  Millions$ 4  Millions
Zoetis Inc   1.10 $ 2,666.000  Millions$ 2,425  Millions
Treace Medical Concepts Inc   1.09 $ 42.938  Millions$ 39  Millions
Staar Surgical Co  1.09 $ 57.022  Millions$ 53  Millions
Sintx Technologies Inc   1.09 $ 0.557  Millions$ 1  Millions
Petvivo Holdings Inc   1.09 $ 0.476  Millions$ 0  Millions
Penumbra Inc  1.08 $ 461.228  Millions$ 427  Millions
Biogen Inc   1.08 $ 2,404.200  Millions$ 2,231  Millions
Vertex Pharmaceuticals Inc  1.07 $ 1,651.300  Millions$ 1,543  Millions
Hyperfine Inc   1.07 $ 6.000  Millions$ 6  Millions
Insmed Inc  1.07 $ 122.938  Millions$ 115  Millions
Catheter Precision Inc   1.05 $ 0.063  Millions$ 0  Millions
Zimmer Biomet Holdings Inc   1.05 $ 2,493.700  Millions$ 2,367  Millions
Seer Inc   1.05 $ 8.000  Millions$ 8  Millions

Date modified: 2026-09-08T15:11:39+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.